EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma

Léna Royston, Aude Jary iD, Carolina A Berini, Tsoarello Mabanga, John Lin, Amélie Pagliuzza, Nicolas Chomont iD, Ivan V Litvinov, Alexandra Calmy iD, Valentin Leducq iD, Vincent Calvez, Anne-Geneviève Marcelin und 2 weitere

Open Forum Infectious Diseases · 30.07.2024 · 11 (8)

DOI: 10.1093/ofid/ofae404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 12.07.2024. Verfasst von Léna Royston und 13 weiteren Autor:innen. Beteiligte Einrichtung: Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de la Recherche Québec-Santé, FRQS, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reemergence of human herpesvirus 8 (HHV-8)–induced Kaposi sarcoma (KS) in people living with HIV (PLWH) despite antiretroviral therapy (ART) poses a clinical challenge because they already have favorable CD4 T-cell numbers and undetectable viral loads. We observed that clinical presentation in PLWH on ART resembled classic KS found in older HIV-uninfected patients and hypothesized that immunosenescence may thus play a role in occurrence of KS on ART. We compared viral and immune factors implicated in the development of KS in ART-treated PLWH (HIV KS) and HIV-uninfected classic KS patients (cKS), compared to controls without KS (HIV Control, cControls respectively).

Methods

Plasma, peripheral blood mononuclear cell, and skin tissues were obtained from 11 HIV KS and 11 cKS patients and 2 groups of age-matched controls.

Results

HIV KS participants were younger than cKS (aged 53 vs 75 years). HHV-8 genotypes did not differ between groups. Despite the younger age and a lower CD4/CD8 ratio, activated, exhausted, and senescent T-cell frequencies were similar between HIV KS and cKS. Anti–HHV-8 immunoglobulin G levels were higher and circulating HHV-8 DNA lower in HIV KS compared with cKS. Circulating platelet-derived growth factors AA-BB and granulocyte colony-stimulating factors were higher in HIV KS We observed similar levels of HHV-8 DNA and PD-1 expression in skin lesions from HIV KS and cKS patients.

Conclusions

Altogether, early immune senescence could be involved in the development of KS in ART-treated PLWH. Higher anti–HHV-8 immunoglobulin G levels could be linked with lower circulating viral load. Such insights should help developing therapeutical strategies to prevent development and treat KS in PLWH on ART.

Schlagwörter

Stichwörter der Autor:innen

Kaposi sarcomacellular immunityhuman herpesvirus 8human immunodeficiency virushumoral immunity

Autor:innen und Institutionen

  • Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
  • Research Institute of the McGill University Health Centre, Infectious Diseases and Immunity in Global Health Program, Montreal, QC, Canada.
  • Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, P…
  • Centre de Recherche du CHUM, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada.
  • HIV Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.

ORCID-Profile: Aude Jary, Nicolas Chomont, Alexandra Calmy, Valentin Leducq, Stéphane Isnard, Jean-Pierre Routy

Förderung

  • Fonds de la Recherche Québec-Santé
  • FRQS
  • Canadian Institutes of Health Research
  • Canadian Foundation for AIDS Research
  • “Fonds de perfectionnement” of the Geneva University Hospitals
  • Swiss National Science Foundation
  • McGill University

Zitieren

APA

Royston, L., Jary, A., Berini, C. A., Mabanga, T., Lin, J., Pagliuzza, A., Chomont, N., Litvinov, I. V., Calmy, A., Leducq, V., Calvez, V., Marcelin, A. G., Isnard, S., & Routy, J. P. (2024). Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma. Open Forum Infectious Diseases, 11(8). https://doi.org/10.1093/ofid/ofae404

Vancouver

Royston L, Jary A, Berini CA, Mabanga T, Lin J, Pagliuzza A, et al. Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma. Open Forum Infectious Diseases. 2024;11(8). doi:10.1093/ofid/ofae404

BibTeX
@article{Royston2024,
  author = {Royston, Léna and Jary, Aude and Berini, Carolina A and Mabanga, Tsoarello and Lin, John and Pagliuzza, Amélie and Chomont, Nicolas and Litvinov, Ivan V and Calmy, Alexandra and Leducq, Valentin and Calvez, Vincent and Marcelin, Anne-Geneviève and Isnard, Stéphane and Routy, Jean-Pierre},
  title = {Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma},
  journal = {Open Forum Infectious Diseases},
  year = {2024},
  volume = {11},
  number = {8},
  doi = {10.1093/ofid/ofae404}
}
Kostenlos starten →